Inicio > Cardiología > Aspectos fisiopatológicos de la depresión en el síndrome coronario agudo. Pronóstico, evolución y perspectiva de tratamiento. Artículo de revisión > Página 9

Aspectos fisiopatológicos de la depresión en el síndrome coronario agudo. Pronóstico, evolución y perspectiva de tratamiento. Artículo de revisión

161. Everson SA, Roberts ER, Goldberg DE, et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 1998;158:1133–1138.

162. Whooley MA, Browner WS, for the Study of Osteoporotic Fractures Research Group. Association between depressive symptoms and mortality in older women. Arch Intern Med. 1998;158:2129–2135.

163. Colantonio A, Kasi SV, Ostfeld AM. Depressive symptoms and other psychosocial factors as predictors of stroke in the elderly. Am J Epidemiol. 1992;136:884–894.

164. Vogt T, Pope C, Mullooly J. Mental health status as a predictor of morbidity and mortality: a 15 year follow-up of members of a health maintenance organization. Am J Public Health. 1994;84:227–231.

165. Thomas C, Kelman HR, Kennedy GR, et al. Depressive symptoms and mortality in elderly persons. J Gerontol. 1992;47(suppl 2):S80–S87.

166. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;3:263–276.

167. Tell GS, Fried LP, Hermanson B, et al, for the Cardiovascular Health Study (CHS) collaborative group. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol. 1993;3:358–366.

168. Ives GD, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol. 1995;5:278–285.

169. US Department of Health and Human Services. International Classification of Diseases. 9th rev. Vol 1. 2nd ed. Washington, DC: US Department of Health and Human Services; 1980. DHHS publication: (PHS) 80–1260.

170. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;3:385–401. Shrout PE, Yager TJ. Reliability and validation of screening scales: effect of reducing scale length. J Clin Epidemiol. 1989;42:69–78.

171. Whooley MA, Avins AL, Miranda J, et al. Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med. 1997;12:439–445.

172. SAS Institute Inc. Phreg, Corr, and NPAR1WAY procedures. In:SAS/STAT User’s Guide. Version 6. Vol 1 and 2. 4th ed. Cary, NC: SAS Institute Inc; 1992.

173. Kannel WB, Vokonas PS. Primary risk factors for coronary heart disease in the elderly: the Framingham Study. In: Wenger NK, Furberg CD, Pitt E, eds. Coronary Heart Disease in the Elderly. New York: Elsevier; 1986:60–95.

174. Rose G, Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. BMJ. 1986;293:306–7.

175. Langer RD, Ganiats TG, Barrett-Connor E. Paradoxical survival of elderly men with high blood pressure. BMJ. 1989;298:1356–1358.

176. Mattila K, Haavisto M, Rajala S, et al. Blood pressure and five year survival in the very old. BMJ. 1988;296:887–889.

177. Dimsdale JE. Coronary heart disease in women: personality and stress-induced biological responses. Ann Behav Med. 1993;15:119–123.

178. Fielding R. Depression and acute myocardial infarction: a review and reinterpretation. Sci Med. 1991;32:1017–1027.

179. Haft JI. Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis. 1974;17:73–86.

180. Hjemdahl P, Larsson T, Wallen NH. Effects of stress and b -blockade on platelet function. Circulation. 1991;84(suppl VI):44–61

181. Barth, J., Schumacher, M. & Herrmann-Lingen,C. (2004) Depression as a risk factor for mortalityin patients with coronary heartdisease: a meta-analysis. Psychosomatic Medicine, , 66 , 802-813.

182. Berkman, L. F., Blumenthal, J., Burg, M., l et al (2003) l Effects oftreating depression andlow perceived social support on clinical events after myocardialinfarction: the Enhancing Recoveryin Coronary Heart Disease. Patients (ENRICHD) Randomized Trial. JAMA, , 289, 3106-3116.

183. Frasure-Smith, N. (2005) Presidential address.In Proceedings ofthe 63rd Annual Meeting ofthe American y Psychosomatic Society. . American Psychosomatic Society.

184. Frasure-Smith, N., Lesperance, F., Prince, R. H., et l al (1997) Randomised trial of home-based psychosocial i nursing intervention for patients recovering from. myocardialinfarction. Lancet, , 350 , 473-479.

185. Freedman, L. S. & Schatzkin, A. (1992) Sample size ii for studyingintermediate endpoints withinintervention . trials or observational studies. American Journal of y Epidemiology, , 136 ,1148-1159.

186. Glassman, A.H., Roose, S. P. & Bigger, J.T., Jr (1993) The safetyoftricyclic antidepressantsin cardiac patients. . Risk-benefit reconsidered. JAMA, 269, 2673-2675.

187. Van Melle, J. P., de Jonge, P., Spijkerman,T. A., et al (2004) Prognostic association of depression following myocardialinfarction with mortality and cardiovascular. events: a meta-analysis. Psychosomatic Medicine, 66, 814-822.

188. Van Melle, J. P., de Jonge, P., Honig, A., l et al (2007) l Effects of antidepressanttreatment onlong-term depression status and cardiac prognosisin depressed MI . patients. y British Journal of Psychiatry, 190 , 460-466.

189. Lespérance F, Frasure-Smith N, Koszycki D, Laliberte MA, van Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial. JAMA 2007; 297: 367-79.

190. Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev 2005; 24: 205-14.

191. Van den Brink RH, van Melle JP, Honig A, Schene AH, Crijns HJ, Lambert FP, et al. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT). Am Heart J 2002; 144: 219-25.

192. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, et al; Sertraline AntiDepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation. 2003; 108: 939-44.

193. Ziegelstein RC, Meuchel J, Kim TJ, Latif M, Alvarez W, Dasgupta N, et al. Selective serotonin reuptake inhibitor use by patients with acute coronary syndromes. Am J Med 2007; 120: 525-30.

194. Sauer WH, Berlin JA, Kimmel SE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 2003; 108: 32-6.

195. Glassman AH, O’Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina: Sertraline Antidepressant Heart Attack Randomized Trial. JAMA 2002; 288: 701-9.

196. Writing Committee for the ENRICHD Investigators. The effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106-16.

197. Van den Brink, R. H., Van Melle, J. P., Honig, A., et al (2002) Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND–IT). American Heart Journal, 144, 219– 225.

198. Van Melle, J. P., De Jonge, P., Spijkerman, T. A., et al (2004) Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosomatic Medicine, 66, 814– 822.

199. C. B., Youngblood, M. E., Catellier, D., et al (2005) Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Archives of General Psychiatry, 62, 792– 798.

200. Van Melle, J. P., de Jonge, P., Honig, A., et al (2007) Effects of antidepressant treatment on long-term depression status and cardiac prognosis in depressed MI patients. British Journal of Psychiatry, 190, 460– 466